Genta Completes Financing of Up to $12.0 Million
March 29, 2012 08:05 ET
|
Genta Incorporated
-- Proceeds enable initiation of randomized trials of tesetaxel in both gastric and breast cancer --
-- Transaction eliminates conversion price reset and requirement for reverse stock split...
Genta Incorporated Reports Fourth Quarter and 2011 Year-End Financial Results
March 28, 2012 07:58 ET
|
Genta Incorporated
BERKELEY HEIGHTS, N.J., March 28, 2012 (GLOBE NEWSWIRE) -- Genta Incorporated (OTCBB:GNTA) today reported results for the quarter and year ended December 31, 2011. For the fourth quarter of 2011, the...
Genta Incorporated to Present at 14th Annual BIO CEO & Investor Conference
February 06, 2012 08:05 ET
|
Genta Incorporated
BERKELEY HEIGHTS, N.J., Feb. 6, 2012 (GLOBE NEWSWIRE) -- Genta Incorporated (OTCBB:GNTA) today announced that the Company's Chairman and Chief Executive Officer, Dr. Raymond P. Warrell, Jr., will...
New Clinical Trial Confirms the Activity of Tesetaxel in Patients With Advanced Gastric Cancer
January 19, 2012 08:05 ET
|
Genta Incorporated
BERKELEY HEIGHTS, N.J., Jan. 19, 2012 (GLOBE NEWSWIRE) -- Genta Incorporated (OTCBB:GNTA.OB) today announced results from the Company's Phase 2b, confirmatory clinical trial of tesetaxel in patients...
Genta Incorporated to Present at the 5th Annual OneMedForum in San Francisco
January 03, 2012 08:05 ET
|
Genta Incorporated
BERKELEY HEIGHTS, N.J., Jan. 3, 2012 (GLOBE NEWSWIRE) -- Genta Incorporated (OTCBB:GNTA.OB) announced that the Company's Chairman and Chief Executive Officer, Dr. Raymond P. Warrell, Jr., will provide...
Genta Announces Results From Clinical Trial of Tesetaxel as Initial Chemotherapy for Women With Recurrent Breast Cancer
December 08, 2011 08:05 ET
|
Genta Incorporated
BERKELEY HEIGHTS, N.J., Dec. 8, 2011 (GLOBE NEWSWIRE) -- Genta Incorporated (OTCBB:GNTA.OB) today announced presentation of results from the Company's Phase 2b clinical trial using tesetaxel as...
Genta Incorporated Reports Third Quarter 2011 Financial Results and Recent Corporate Highlights
November 10, 2011 07:00 ET
|
Genta Incorporated
-- Tesetaxel Clinical Data Pending Multiple Presentations
-- Response and progression-free survival in 1st-line breast cancer expected at 2011 San Antonio Breast Cancer Symposium in December
--...
Genta Incorporated to Host Conference Call to Discuss Third Quarter 2011 Highlights and Financial Results
November 03, 2011 08:05 ET
|
Genta Incorporated
BERKELEY HEIGHTS, N.J., Nov. 3, 2011 (GLOBE NEWSWIRE) -- Genta Incorporated (OTC:GNTA.OB) announced today that the Company will release its third quarter 2011 financial results on Thursday, November...
Genta Incorporated to Present at the Rodman & Renshaw Annual Global Investment Conference
September 08, 2011 08:05 ET
|
Genta Incorporated
BERKELEY HEIGHTS, N.J., Sept. 8, 2011 (GLOBE NEWSWIRE) -- Genta Incorporated (OTCBB:GNTA) announced that the Company's Chairman and Chief Executive Officer, Dr. Raymond P. Warrell, Jr., will provide a...
Genta Completes Financing of Up to $12.7 Million
September 06, 2011 08:11 ET
|
Genta Incorporated
Proceeds expected to enable initiation of global registration studies for tesetaxel
Accelerated development of pipeline products anticipated
BERKELEY HEIGHTS, N.J., Sept. 6, 2011 (GLOBE...